查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1964106

十字韌帶修復手術市場 - 全球產業規模、佔有率、趨勢、機會、預測：按手術類型、最終用途、地區和競爭格局分類，2021-2031年

Cruciate Ligament Repair Procedures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Procedure Type, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球十字韌帶修復手術市場預計將從 2025 年的 150.6 億美元成長到 2031 年的 223.6 億美元，複合年成長率為 6.81%。

これらの外科的介入は、自體骨移植、同種移植片、または合成代替物を用いて損傷した膝の前十字靭帯または後十字靭帯を重組し、関節の安定性を回復することを目的としております。本市場の成長は主に、スポーツ関連損傷の増加傾向と、一般人口における高負荷身体活動への参加率上昇によって牽引されております。例えば、ニュージーランド前十字靭帯登録機構（ACL Registry）の2024年報告によれば、ラグビーは依然として患者における損傷の主要原因であり、症例の23%を占めており、コンタクトスポーツと重組手術の需要との直接的な関連性を浮き彫りにしています。さらに、低侵襲技術や移植片固定技術の進歩は、患者の治療成果を向上させることで、市場の成長を継続的に支えています。

市場概覽
預測期 2027-2031
市場規模：2025年 150.6億美元
市場規模：2031年 223.6億美元
複合年成長率：2026-2031年 6.81%
成長最快的細分市場 前十字韌帶修復
最大的市場 北美洲

然而，市場擴張的一大障礙是這些複雜手術及術後復原的高昂費用。許多醫療體系的保險覆蓋範圍有限，造成了經濟壁壘，使患者無法獲得先進的治療方案。此外，諸如移植失敗和感染等併發症的潛在風險需要嚴格的長期管理，這可能會讓對費用敏感的患者望而卻步。這些經濟因素阻礙了十字韌帶修復方案的廣泛應用，尤其是在發展中國家。

市場促進因素

高強度運動傷害的發生率不斷上升，這主要歸因於運動參與度的活性化和現代運動競爭的加劇，也是推動十字韌帶（ACL）修復市場擴張的主要因素。這一趨勢在女性運動員中尤其明顯，她們在足球、籃球等需要頻繁轉體的運動中，生理上更容易發生韌帶斷裂。哈佛大學學報（Harvard Gazette）2024年12月刊引用的一項最新Meta分析證實了這種差異，該分析顯示，女性運動員發生ACL損傷的可能性是男性運動員的1.7倍。如此高的發生率直接轉化為對重組手術和醫療設備的持續需求，從而推動了該行業的財務成長。例如，史密斯醫療（Smith & Nephew）在2024年2月報告稱，其運動醫學關節修復業務在2023年實現了8.8%的潛在收入成長，這主要得益於全球手術數量的激增。

同時に、新規の生物学的植入や再生医療用スキャフォールドの開発が進み、従来の移植片による重組術の限界を克服することで治療基準を革新しています。外科医は生体統合技術を積極的に採用し、自体の靭帯を補強することで治癒を促進し、高リスク患者群における再斷裂率を大幅に低減しています。こうした革新技術は、再手術のリスクなく負傷前のパフォーマンスレベルに復帰するための耐久性のある解決策を必要とする、若年かつ活動的な患者にとって極めて重要です。この進歩を示す事例として、アースレックス社は2024年12月、自社開発の「InternalBrace」靭帯増強術に関する臨床調査において、若年アスリートにおける前十字靭帯（ACL）再斷裂リスクが標準修復法と比較して88％低減したことを報告しました。このような進歩は臨床成果を向上させ、高品質な修復ソリューションの市場普及を促進し、包括的な生物学的修復への注目を高めています。

市場挑戰

由於手術費用高且術後復健必不可少，全球十字韌帶修復手術市場面臨許多挑戰。重組手術涉及大量的費用，包括手術費、住院費和先進的移植技術，而長期且昂貴的物理治療對於取得良好的治療效果至關重要。在健保覆蓋範圍有限或自付費用高的地區，這些費用給患者帶來了沉重的經濟負擔。這種經濟壓力迫使許多患者，尤其是在對費用敏感的市場和開發中國家，選擇非手術治療或延遲治療，直接導致手術數量下降。

近期有關傷病治療成本的數據凸顯了這項經濟挑戰的嚴峻。根據美國意外傷害賠償公司 (ACC) 2024 年的報告，20-29 歲年齡層中，標準前十字韌帶損傷的平均康復費用約為 14,000 美元。如此高昂的單次治療費用對許多潛在患者而言構成了巨大的經濟障礙。因此，由於經濟限制，許多人群無法獲得這些旨在恢復關節穩定性的重要手術，從而阻礙了市場擴張。

市場趨勢

橋接加強型前十字韌帶修復（BEAR）技術的應用，從根本上改變了市場重心，使其從傳統的自體重組轉向生物修復。與需要採集健康組織進行自體移植的標準方法不同，這種生物工程植入能夠保留原有韌帶，並利用牛膠原蛋白支架橋接斷裂，從而促進人體自身的癒合。由於此方法能夠保留本體感覺和原有的解剖結構，因此正迅速被希望避免供體部位併發症的患者所接受。根據2025年3月發布的新聞稿“FDA核准Miach Orthopaedics公司BEAR植入的擴大適應症”，Miach Orthopaedics公司報告稱，通過臨床試驗和商業化，已有超過5000名患者接受了BEAR植入的治療。

同時，穿戴式感測器在術後照護的應用，正透過實現遠端、數據驅動的病患管理，革新復健通訊協定。外科醫師正利用互聯健康平台，透過即時監測患者的活動範圍、步數和依從性，直接應對高成本且管理不善的物理治療所帶來的挑戰。這種整合實現了早期療育和個人化復健路徑，顯著提升了現代復健解決方案的提案。例如，根據捷邁Biomet公司2025年12月發布的新聞稿《捷邁Biomet與OneStep合作，提供更強大的行動數據》，該公司整合的行動智慧技術目前每天分析超過一百萬個步態週期，凸顯了用於最佳化患者療效的數據規模之龐大。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：十字韌帶修復手術的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 手術類型（前十字韌帶（ACL）修補、後十字韌帶（PCL）修補）
    • 依最終使用者（醫院、門診手術中心等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美十字韌帶修復手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲十字韌帶修復手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區十字韌帶修復手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲十字韌帶修復手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲十字韌帶修復手術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球十字韌帶修復手術市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Zimmer Biomet Holdings Inc
  • Stryker Corp
  • Smith & Nephew plc
  • Arthrex Inc
  • Boston Scientific Corporation
  • B Braun SE
  • athenahealth Inc
  • Wright Medical Group NV

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 21827

The Global Cruciate Ligament Repair Procedures Market is projected to expand from USD 15.06 Billion in 2025 to USD 22.36 Billion by 2031, reflecting a CAGR of 6.81%. These surgical interventions aim to reconstruct damaged anterior or posterior knee ligaments using autografts, allografts, or synthetic substitutes to restore joint stability. The market is primarily propelled by the increasing prevalence of sports-related injuries and higher participation in high-impact physical activities among the general population. For instance, the New Zealand ACL Registry reported in 2024 that rugby remained the leading cause of injury among patients, responsible for 23% of cases, highlighting the direct link between contact sports and the demand for reconstructive surgeries. Additionally, advancements in minimally invasive techniques and graft fixation technologies continue to support market growth by enhancing patient outcomes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 15.06 Billion
Market Size 2031USD 22.36 Billion
CAGR 2026-20316.81%
Fastest Growing SegmentAnterior Cruciate Ligament Repair
Largest MarketNorth America

However, a significant barrier to market expansion is the substantial cost associated with these complex surgeries and the mandatory post-operative rehabilitation. Limited reimbursement coverage in many healthcare systems creates financial obstacles that restrict patient access to advanced treatment options. Furthermore, the potential risks of complications, such as graft failure or infection, necessitate rigorous long-term management, which may discourage cost-sensitive patients from undergoing these essential procedures. These economic factors collectively present a hurdle to the widespread adoption of cruciate ligament repair solutions, particularly within developing markets.

Market Driver

The rising incidence of high-impact sports-related injuries serves as a major catalyst for the expansion of the cruciate ligament repair market, driven by intensifying athletic participation and the competitive nature of modern sports. This trend is particularly evident among female athletes, who are physiologically more prone to ligament ruptures during pivot-heavy activities like soccer and basketball. A recent meta-analysis cited by the Harvard Gazette in December 2024 underscores this disparity, indicating that female athletes sustain anterior cruciate ligament (ACL) injuries at a rate 1.7 times higher than their male counterparts. This elevated frequency translates directly into sustained demand for reconstructive surgeries and medical devices, bolstering the sector's financial trajectory; for example, Smith+Nephew reported in February 2024 that their Sports Medicine Joint Repair business achieved an 8.8% underlying revenue growth in 2023, largely due to the global surge in procedure volumes.

Simultaneously, the development of novel biologic implants and regenerative scaffolds is revolutionizing treatment standards by addressing the limitations of traditional graft reconstructions. Surgeons are increasingly adopting bio-integrative technologies that augment the native ligament, thereby accelerating healing and significantly lowering failure rates in high-risk patient populations. These innovations are critical for younger, active patients who require durable solutions to return to pre-injury performance levels without the setbacks of revision surgery. Illustrating this progress, Arthrex reported in December 2024 that clinical research on their InternalBrace ligament augmentation technique demonstrated an 88% reduction in the risk of ACL retears in young athletes compared to standard repair methods. Such advancements improve clinical outcomes and encourage wider market adoption of premium repair solutions, shifting focus toward comprehensive biological restoration.

Market Challenge

The Global Cruciate Ligament Repair Procedures Market faces a significant obstacle due to the high costs incurred during surgical interventions and the necessary post-operative rehabilitation. Reconstructive procedures involve substantial expenditure on surgical fees, hospital stays, and advanced graft technologies, while successful outcomes rely heavily on prolonged and costly physical therapy. In healthcare systems with limited reimbursement policies or high deductibles, these expenses place a severe financial burden on patients. This economic strain forces many individuals, particularly in cost-sensitive or developing markets, to opt for non-surgical management or delay treatment, thereby directly reducing the volume of procedures performed.

The magnitude of this financial challenge is highlighted by recent data regarding injury management expenses. According to the Accident Compensation Corporation in 2024, the average recovery cost for a standard anterior cruciate ligament injury in the 20 to 29 age demographic was approximately $14,000. This high per-patient cost underscores the affordability gap that exists for many potential candidates. Consequently, market expansion is restricted as economic limitations prevent a wider population from accessing these essential surgeries designed to restore joint stability.

Market Trends

The adoption of Bridge-Enhanced ACL Restoration (BEAR) technology is fundamentally shifting the market focus from traditional graft-based reconstruction to biological restoration. Unlike standard procedures that require harvesting healthy tissue for autografts, this bio-engineered implant preserves the native ligament and utilizes a bovine collagen scaffold to bridge the tear, enabling the body to heal itself. This approach maintains proprioception and native anatomy, driving rapid clinical uptake among patients seeking to avoid donor site morbidity. According to a March 2025 press release titled 'FDA Approves Expanded Use of Miach Orthopaedics' BEAR Implant,' Miach Orthopaedics reported that more than 5,000 patients have been treated with the BEAR Implant through clinical trial and commercial use.

Concurrently, the incorporation of wearable sensors in post-operative care is transforming rehabilitation protocols by enabling remote, data-driven patient management. Surgeons are increasingly leveraging connected health platforms to monitor range of motion, step count, and compliance in real-time, directly addressing the challenge of costly and unmonitored physical therapy. This integration allows for early intervention and personalized recovery pathways, significantly enhancing the value proposition of modern repair solutions. For instance, according to Zimmer Biomet's December 2025 press release, 'Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data,' their integrated mobility intelligence technology now analyzes more than one million gait cycles every day, underscoring the massive scale of data being utilized to optimize patient outcomes.

Key Market Players

  • Zimmer Biomet Holdings Inc
  • Stryker Corp
  • Smith & Nephew plc
  • Arthrex Inc
  • Boston Scientific Corporation
  • B Braun SE
  • athenahealth Inc
  • Wright Medical Group NV

Report Scope

In this report, the Global Cruciate Ligament Repair Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cruciate Ligament Repair Procedures Market, By Procedure Type

  • Anterior Cruciate Ligament (ACL) Repair
  • Posterior Cruciate Ligament (PCL) Repair

Cruciate Ligament Repair Procedures Market, By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Cruciate Ligament Repair Procedures Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cruciate Ligament Repair Procedures Market.

Available Customizations:

Global Cruciate Ligament Repair Procedures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cruciate Ligament Repair Procedures Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Procedure Type (Anterior Cruciate Ligament (ACL) Repair, Posterior Cruciate Ligament (PCL) Repair)
    • 5.2.2. By End-use (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cruciate Ligament Repair Procedures Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Procedure Type
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cruciate Ligament Repair Procedures Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Procedure Type
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Cruciate Ligament Repair Procedures Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Procedure Type
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Cruciate Ligament Repair Procedures Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Procedure Type
        • 6.3.3.2.2. By End-use

7. Europe Cruciate Ligament Repair Procedures Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Procedure Type
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Procedure Type
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Procedure Type
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Procedure Type
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Procedure Type
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Procedure Type
        • 7.3.5.2.2. By End-use

8. Asia Pacific Cruciate Ligament Repair Procedures Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Procedure Type
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Procedure Type
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Procedure Type
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Procedure Type
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Procedure Type
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Procedure Type
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Cruciate Ligament Repair Procedures Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Procedure Type
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cruciate Ligament Repair Procedures Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Procedure Type
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Cruciate Ligament Repair Procedures Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Procedure Type
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Cruciate Ligament Repair Procedures Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Procedure Type
        • 9.3.3.2.2. By End-use

10. South America Cruciate Ligament Repair Procedures Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Procedure Type
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cruciate Ligament Repair Procedures Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Procedure Type
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Cruciate Ligament Repair Procedures Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Procedure Type
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Cruciate Ligament Repair Procedures Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Procedure Type
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cruciate Ligament Repair Procedures Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zimmer Biomet Holdings Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Stryker Corp
  • 15.3. Smith & Nephew plc
  • 15.4. Arthrex Inc
  • 15.5. Boston Scientific Corporation
  • 15.6. B Braun SE
  • 15.7. athenahealth Inc
  • 15.8. Wright Medical Group NV

16. Strategic Recommendations

17. About Us & Disclaimer